FAAH

Fatty acid amide hydrolase or FAAH (oleamide hydrolase, anandamide amidohydrolase) is a member of the serine hydrolase family of enzymes. It was first shown to break down anandamide in 1993. In humans, it is encoded by the gene FAAH.FAAH is an integral membrane hydrolase with a single N-terminal transmembrane domain. In vitro, FAAH has esterase and amidase activity.In vivo, FAAH is the principal catabolic enzyme for a class of bioactive lipids called the fatty acid amides (FAAs).

Cat. No.	Product name	CAS No.	Purity
T11255	FAAH-IN-1	1242441-47-9	98%
T11255	FAAH-IN-1 is a fatty acid amide hydrolase (FAAH) inhibitor, with IC50s of 145 nM and 650 nM for rat and human FAAH, respectively.
T16847	SA 47	792236-07-8	98%
T16847	SA 47 is a selective and effective inhibitor of fatty acid amide hydrolase and carbamate.
T67745	CB2R/FAAH modulator-2	2876918-68-0	98%
T67745	CB2R/FAAH modulator-2 (compound 26) is a dual modulator targeting at CB2R and FAAH. CB2R/FAAH modulator-2 acts as a CB2R agonist and FAAH inhibitor, the Ki value...
T12826	SA57	1346169-63-8	98%
T12826	SA57 is a potent, selective inhibitor of FAAH(IC50s of 3.2 nM and 1.9 nM for mouse and human FAAH).
T63536	Dual FAAH/sEH-IN-1	2756099-59-7	98%
T63536	Dual FAAH/sEH-IN-1 (compound 3) is a high affinity dual inhibitor of FAAH (fatty acid amide hydrolase) and sEH (soluble epoxide hydrolase), with IC50 values of 7...
T67747	CB2R/FAAH modulator-3	2876918-67-9	98%
T67747	CB2R/FAAH modulator-3 (compound 27) is a modulator targeting at CB2R and FAAH. CB2R/FAAH modulator-3 acts as a CB2R agonist and FAAH inhibitor, the Ki values are...
T28353	PDP-EA	861891-72-7	98%
T28353	PDP-EA is an activator of fatty acid amide hydrolase(FAAH) and enhances the amidohydrolase activity of FAAH.
T16515	PF 750	959151-50-9	98%
T16515	PF 750 is a selective and covalent inhibitor of FAAH. PF 750 shows IC50s varying from 16.2 to 595 nM in different incubation times.
T9374	AA38-3	65815-76-1
T9374	AA38-3 inhibites three SHs (ABHD6, ABHD11, and FAAH)
T6714	URB-597	546141-08-6	97.84%
T6714	URB597 is an effective, orally bioavailable FAAH inhibitor (IC50: 4.6 nM), and no effect on other cannabinoid-related targets.
T2859	Biochanin A	491-80-5	98%
T2859	Biochanin A is an isoflavone derivative isolated from red clover Trifolium pratense with anticarcinogenic properties. Biochanin A is a naturally occurring fatty ...
T11256	FAAH inhibitor 1	326866-17-5	98.05%
T11256	FAAH inhibitor 1 is an effective FAAH inhibitor with an IC50 of 18 nM.
T15802	LY2183240	874902-19-9	98.17%
T15802	LY2183240 inhibits fatty acid amide hydrolase (FAAH) activity (IC50 = 12.4 nM). LY2183240 is a novel and highly effective blocker of anandamide uptake (IC50 = 27...
T5357	ARN272	488793-85-7	98.23%
T5357	ARN272 is a FAAH-like anandamide transporter (FLAT) inhibitor (IC50: 1.8 μM).
T7688	4-Nonylphenylboronic acid	256383-45-6	99.13%
T7688	4-Nonylphenylboronic acid is a inhibitor of FAAH.
T15268	FAAH-IN-2	184475-71-6	99.18%
T15268	FAAH-IN-2 is a potent inhibitor of FAAH(fatty acid amide hydrolase).
T1325	Carprofen	53716-49-7	99.45%
T1325	Carprofen is a propionic acid derivate and nonsteroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic, and antipyretic activities.
T8646	URB937	1357160-72-5	99.55%
T8646	URB937 is an inhibitor of FAAH and increases anandamide levels(IC50 : 26.8 nM).
T4859	1-Monomyristin	589-68-4	99.58%
T4859	1-Myristoyl-rac-glycerol, a 1-monoglyceride of myristic acid, has antibacterial activity against several Gram-positive bacterial strains. 1-Myristoyl-rac-glycero...
T6043	PF-3845	1196109-52-0	99.58%
T6043	PF-3845 is a potent, selective and irreversible FAAH inhibitor with Ki of 230 nM, showing negligible activity against FAAH2.